Open in interactive viewer → charts, metric popovers & call review

KRUK's Balancing Act: Flat H1 Profit Masks a Spanish Turnaround and Deliberate Capital Discipline

While Poland and Romania get competitive, KRUK pivots to Spain, advances its fund conversion, and stays confident on full-year deployments despite currency drags.
KRU.WA · Earnings Call · 2026-08-27

KRUK's Balancing Act

KRUK Spólka Akcyjna reported a solid but uninspiring first half of 2026: “The 6 months of 2026 meant PLN 555 million of net profit, a solid result.” — Unknown Executive · 2026-08-27 Yet the headline flatness conceals a more nuanced story. Recoveries grew 5%, assets grew 12%, and cash EBITDA rose 8% — evidence that the underlying portfolio engine is still expanding. The company is playing a careful game of capital allocation, choosing where to press the gas and where to hit the brake in a competitive environment that shows no signs of easing.

Competition and Capital Allocation

In Poland, the largest market, portfolio supply was small but high-quality, with prices reaching 34% of nominal. Romania saw even higher price tension at 46%, and competition was similarly intense. Management was explicit about their response: “we can press the gas pedal in less competitive market and press the brake pedal in more competitive markets.” — Unknown Executive · 2026-08-27 They chose to brake, sacrificing market share in both countries rather than compromising on IRR. This is a deliberate strategy to preserve return discipline, and it's consistent with the company's long-held belief that it can sit out quarters when pricing is unattractive.

The group's investment activity reflects this: “we secured about PLN 860 million of new investments. This is still not even half of what we expect to invest this year.” — Unknown Executive · 2026-08-27 Full-year guidance remains at PLN 2.5 billion, but management acknowledges the risk is skewed to the downside if competition remains fierce. In the Q&A, the CFO reiterated an expectation for full-year gross IRRs "in the 20s," just below the 21% seen in 2025.

Spain: The Turnaround Takes Hold

The most encouraging development is Spain. After years of write-downs and operational struggles, the market finally delivered a strong quarter. Management was upbeat: “I think we've gone a long way from January 2026 to today, the legal process, how we managed the results are much better today than they used to be.” — Unknown Executive · 2026-08-27 The Spanish business is now profitable at the EBITDA level, recoveries are rising, and the company has rebuilt its credibility to re-enter the buying market. With low prices in Spain and an 80% market share in the recent deals, the opportunity set is clearly more attractive than in Poland or Romania.

This aligns with the company's prior stance. In February, management guided to “somewhere between PLN 2.4 billion, PLN 2.7 billion in 2026” — Michal Zasepa, Host / Company Representative · 2026-02-27 for purchases, and in October 2025 they reaffirmed their commitment to Spain: “we believe the market is big enough and our competitive position is strong enough for us to continue to earn money in Spain an adequate return.” — Michal Zasepa, CFO · 2025-10-30 The current results validate that patience.

Currency Headwinds and Strategic Transformation

Not everything is improving. The depreciation of the Romanian leu (RON) trimmed revenue by roughly PLN 50 million, and management described it as a one-off event tied to political uncertainty. The currency drag is a reminder of the external risks that can offset operational gains. Meanwhile, the company is advancing two transformational projects: the IT system replacement and the reorganization into an alternative investment fund, on track for 2027. The MVP for the new Polish system was released in July, marking a major milestone.

One of the more interesting nuances in the call was the explanation of why recoveries are growing slower than the carrying value of the portfolio. The company is buying assets with recovery curves assumed to stretch out to 20 years, with a cash-flow breakeven of about 6 years. As management put it, recoveries are "relatively spread flat for a long period of time," so asset growth naturally outpaces near-term recoveries. This longer-duration profile is a deliberate response to high competition and rising prices, and it means the true payoff will show up years down the road. The Cash EBITDA metric, which strips out the purchase price, provides a better view of operating cash flow, and it grew 8%.

Outlook: Growth Hinges on Recoveries

Management expects a stronger second half, but the biggest variable remains recovery performance.

the biggest sensitivity on whether we'll grow by this or 1% for the full year will be whether our recoveries will be 2%, 3% smaller or higher versus our plans.

Unknown Executive · 2026-08-27
That sensitivity is amplified by a market where similar level of supply is expected across most geographies, and where competition is unlikely to fade. KRUK's edge has always been its ability to move capital across markets and sit out when prices are irrational. This quarter shows that discipline is intact, even as the headline profit number remains flat. The real test will come in H2, when the company expects to deploy a significant portion of its PLN 2.5 billion budget and Spain begins to contribute more materially.